The aim of the present study was to investigate the molecular mechanism of carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates recovered from Libyan hospitals between April 2013 and April 2014. In total, 49 strains (24 P. aeruginosa and 25 A. baumannii) were isolated, including 21 P. aeruginosa and 22 A. baumannii isolates (87.75%) resistant to imipenem (minimum inhibitory concentrations ≥16 μg/ml). The blaVIM-2 gene was detected in 19 P. aeruginosa isolates. All imipenem-resistant P. aeruginosa isolates showed the presence of OprD mutations. Acquired OXA-carbapenemase-encoding genes were present in all A. baumannii isolates: blaOXA-23 (n=19) and blaOXA-24 (n=3). Finally, a total of 13 and 17 different sequence types were assigned to the 21 P. aeruginosa and the 22 A. baumannii carbapenem-resistant isolates, respectively. This study is the first report describing imipenem-resistant P. aeruginosa and A. baumannii isolated from patients in Libya. We report the first case of co-occurrence of blaVIM-2 with oprD porin loss in identical isolates of P. aeruginosa in Libya and demonstrate that these oprD mutations can be used as a tool to study the clonality in P. aeruginosa isolates. We also report the first identification of multidrug-resistant A. baumannii isolates harboring blaOXA-23-like, blaOXA-24-like, and blaOXA-48-like genes in Libya.
Get full access to this article
View all access options for this article.
References
1.
Al BayssariC., DieneS.M., LoucifL., GuptaS.K., DabboussiF., MallatH., HamzeM., and RolainJ.M.. 2014. Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of oprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from lebanon. Antimicrob. Agents Chemother., 58:4966–4970.
2.
Al-AgamyM.H., KhalafN.G., TawfickM.M., ShiblA.M., and El KholyA.. 2014. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int. J. Infect. Dis., 22:49–54.
3.
BakourS., AlsharapyS.A., TouatiA., and RolainJ.M.. 2014. Characterization of Acinetobacter baumannii clinical isolates carrying bla carbapenemase and 16S rRNA methylase armA genes in Yemen. Microb. Drug Resist., 20:604–609.
4.
BakourS., KempfM., TouatiA., AitA.A., HaouchineD., SahliF., and RolainJ.M.. 2012. Carbapenemase-producing Acinetobacter baumannii in two university hospitals in Algeria. J. Med. Microbiol., 61:1341–1343.
5.
BartualS.G., SeifertH., HipplerC., LuzonM.A., WisplinghoffH., and Rodriguez-ValeraF.. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol., 43:4382–4390.
6.
CabotG., Ocampo-SosaA.A., TubauF., MaciaM.D., RodriguezC., MoyaB., ZamoranoL., SuarezC., PenaC., Martinez-MartinezL., and OliverA.. 2011. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob. Agents Chemother., 55:1906–1911.
7.
ChouchaniC., MarrakchiR., and El SalabiA.2011. Evolution of beta-lactams resistance in Gram-negative bacteria in Tunisia. Crit. Rev. Microbiol., 37:167–177.
8.
ChouchaniC., MarrakchiR., FerchichiL., El SalabiA., and WalshT.R.2011. VIM and IMP metallo-beta-lactamases and other extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from environmental samples in a Tunisian hospital. APMIS, 119:725–732.
9.
CornagliaG., GiamarellouH., and RossoliniG.M.2011. Metallo-beta-lactamases: a last frontier for beta-lactams?. Lancet Infect. Dis., 11:381–393.
10.
CorvecS., PoirelL., DecousserJ.W., AllouchP.Y., DrugeonH., and NordmannP.2006. Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France. Clin. Microbiol. Infect., 12:941–942.
11.
DieneS.M., FallB., KempfM., FenollarF., SowK., NiangB., WadeB., RaoultD., and RolainJ.M.2013. Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal. Int. J. Infect. Dis., 17:209–210.
12.
DieneS.M., and RolainJ.M.2014. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect., 20:831–838.
13.
DortetL., PoirelL., ErreraC., and NordmannP.2014. CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. J. Clin. Microbiol., 52:2359–2364.
14.
DortetL., PoirelL., and NordmannP.2012. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob. Agents Chemother., 56:6437–6440.
15.
ElA.N., GiskeC.G., JalalS., KeijserB., KronvallG., and WretlindB.2005. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS, 113:187–196.
16.
ElS.A., BorraP.S., TolemanM.A., SamuelsenO., and WalshT.R.2012. Genetic and biochemical characterization of a novel metallo-beta-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob. Agents Chemother., 56:2241–2245.
17.
EllabibM.S., AboshkiwaM., AlmarganiN., ZorganiA., El SalabiA., and El-GumatiM.2013. Detection of metallo-β-lactamase in Pseudomonas aeruginosa from Tripoli, Libya. J. Biomed. Sci., 2:1–6.
18.
EvansB.A., and AmyesS.G.2014. OXA beta-lactamases. Clin. Microbiol. Rev., 27:241–263.
19.
GutierrezO., JuanC., CercenadoE., NavarroF., BouzaE., CollP., PerezJ.L., and OliverA.2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother., 51:4329–4335.
20.
HammamiS., GautierV., GhozziR., DaC.A., Ben-RedjebS., and ArletG.2010. Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin. Microbiol. Infect., 16:189–193.
21.
KempfM., and RolainJ.M.2012. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int. J. Antimicrob. Agents, 39:105–114.
22.
LeeK., KimC.K., YongD., JeongS.H., YumJ.H., SeoY.H., DocquierJ.D., and ChongY.2010. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. J. Microbiol. Methods, 83:149–152.
23.
ListerP.D., WolterD.J., and HansonN.D.2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev., 22:582–610.
24.
LivermoreD.M.2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin. Infect. Dis., 34:634–640.
25.
MansourW., PoirelL., BettaiebD., BouallegueO., BoujaafarN., and NordmannP.2008. Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia. Microb. Drug Resist., 14:289–292.
26.
MavroidiA., TsakrisA., TzelepiE., PournarasS., LoukovaV., and TzouvelekisL.S.2000. Carbapenem-hydrolysing VIM-2 metallo-beta-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother., 46:1041–1042.
27.
NehmeD., LiX.Z., ElliotR., and PooleK.2004. Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB. J. Bacteriol., 186:2973–2983.
28.
NhoS.O., JinJ.S., KimJ.W., OhJ.Y., KimJ., LeeY.C., SeolS.Y., ChoD.T., and LeeJ.C.2008. Dissemination of the blaIMP-1 and blaVIM-2 metallo-beta-lactamase genes among genetically unrelated Pseudomonas aeruginosa isolates in a South Korean hospital. Int. J. Antimicrob. Agents, 31:586–588.
29.
NordmannP., and PoirelL.2014. The difficult-to-control spread of carbapenemase producers in Enterobacteriaceae worldwide. Clin. Microbiol. Infect., 20:821–830.
30.
NordmannP., and PoirelL.2014. Emerging and important antibiotic resistance in Gram negative bacteria: epidemiology, theory and practice. Rev. Med. Suisse, 10:902–907.
31.
PirnayJ.P., DeV.D., MossialosD., VanderkelenA., CornelisP., and ZiziM.2002. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ. Microbiol., 4:872–882.
32.
PoirelL., and NordmannP.2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect., 12:826–836.
33.
RafeiR., DabboussiF., HamzeM., EveillardM., LemarieC., MallatH., RolainJ.M., Joly-GuillouM.L., and KempfM.2014. First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war. Int. J. Infect. Dis., 21:21–23.
34.
Rojo-BezaresB., EstepaV., CebolladaR., deT.M., SomaloS., SeralC., CastilloF.J., TorresC., and SaenzY.2014. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons. Int. J. Med. Microbiol., 304:405–414.
35.
SanbongiY., ShimizuA., SuzukiT., NagasoH., IdaT., MaebashiK., and GotohN.2009. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Microbiol. Immunol., 53:361–367.
36.
SefraouiI., BerrazegM., DrissiM., and RolainJ.M.2014. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012. Microb. Drug Resist., 20:156–161.
37.
TouatiM., DieneS.M., DekhilM., DjahoudiA., RacheracheA., and RolainJ.M.2013. Dissemination of a class I integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria. Antimicrob. Agents Chemother., 57:2426–2427.
38.
YongD., LeeK., YumJ.H., ShinH.B., RossoliniG.M., and ChongY.2002. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol., 40:3798–3801.
39.
ZaferM.M., Al-AgamyM.H., El-MahallawyH.A., AminM.A., and AshourM.S.. 2014. Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed. Res. Int. doi: 10.1155/2014/101635.
